# A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)

> **NCT05361408** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 114 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Zoledronic acid, once
- **DRUG:** Zoledronic acid, twice

## Key facts

- **NCT ID:** NCT05361408
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-11
- **Primary completion:** 2024-02-13
- **Final completion:** 2024-02-13
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05361408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05361408, "A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05361408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*